The Effect of Cinobufacini on Apoptosis and Growth of Endometrial Cancer HEC-1-B Cell Line

周晓红,王玲玲,赵富荣,周怀君

2009-01-01

Abstract:Objective: To investigate the effect of cinobufacini on the apoptosis, growth, and invasion capacity of the endometrial cancer HEC-1-B cells cultured in vitro. Methods: Endometrial cancer HEC-1-B cells were cultured in vitro. After the action of different concentrations (0.2 mg/ml, 2 mg/ml, and 20 mg/ml) of cinobufacini, the growth of HEC-1-B cells was measured by MTT colorimetry. Apoptosis was tested by flow cytometry. The invasion capacity of HEC-1-B cells treated with cinobufacini was detected with transwell chamber model. Results: The cinobufacini effectively inhibited the growth and invasion of HEC-1-B cells, and induced cell apoptosis. The apoptotic rate of HEC-1-B cells not treated with cinobufacini was only 2.5 %, while the apoptotic rate increased to 7.4 %, 44.3 %, and 78.5 %, respectively, after the HEC-1-B cells were exposed to cinobufacini for 24 hours in different concentrations at 0.2 mg/ml, 2 mg/ml, and 20 mg/ml. Statistic analysis showed that the increment was significant (x2=165.4983, P 0.0001). Cinobufacini showed to be cytotoxic at the high concentration. Conclusion: Cinobufacini can inhibit the growth and invasion capacity of HEC-1-B cells by means of inducing apoptosis of the cells.